Skip To Main Content
 

Incident and Prevalent counts by quarter

Incident counts of reported ESRD, 2013 - 2015Q1
2013^ 2014^ 2015^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
0 - 19 276 275 320 296 292 262 237 290 258
20 - 44 3,532 3,273 3,184 3,426 3,656 3,513 3,337 3,417 3,641
45 - 64 12,088 11,444 10,850 11,478 12,123 11,848 11,042 11,556 12,454
65 - 74 7,737 7,497 7,041 7,384 7,998 7,805 7,369 7,815 8,300
75 + 7,324 6,931 6,643 6,803 7,392 7,092 6,434 6,901 7,463
Male 17,995 16,931 16,114 17,061 18,371 17,636 16,403 17,536 18,742
Female 12,962 12,489 11,924 12,326 13,090 12,884 12,016 12,443 13,374
Diabetes 13,828 13,232 12,219 13,039 14,289 13,331 12,388 13,546 14,214
Hypertension 9,025 8,640 8,133 8,428 8,902 8,685 8,119 8,400 9,019
Glomerulonephritis 2,416 2,163 2,186 2,225 2,371 2,351 2,169 2,157 2,253
Cystic Kidney 649 626 650 608 670 681 612 580 634
Other Urologic 367 355 364 324 386 353 355 362 350
Other Cause 2,833 2,725 2,604 2,767 2,820 3,066 2,810 2,729 2,778
Unknown Cause 932 833 773 876 872 854 801 777 787
Missing Cause 907 846 1,109 1,120 1,151 1,199 1,165 1,428 2,081
All 30,957 29,420 28,038 29,387 31,461 30,520 28,419 29,979 32,116

^ Data as of June 30, 2015
* Values for cells with 10 or fewer patients are suppressed.
"." Zero values in this cell.
Point prevalent counts of reported ESRD, 2013 - 2015Q1
2013^ 2014^ 2015^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
0 - 19 7,569 7,559 7,554 7,590 7,607 7,584 7,519 7,547 7,560
20 - 44 103,338 103,617 103,706 103,836 104,268 104,707 104,743 104,832 105,174
45 - 64 287,237 289,753 291,353 293,448 295,438 298,158 299,775 301,456 303,681
65 - 74 142,697 145,081 147,421 149,750 152,067 154,378 156,899 159,309 161,375
75 + 104,287 105,487 106,892 107,937 109,021 110,137 111,038 111,870 112,140
Male 368,989 372,871 376,224 379,730 383,640 387,663 390,817 394,207 397,462
Female 276,054 278,545 280,622 282,751 284,684 287,224 289,081 290,731 292,393
Unknown 85 81 80 80 77 77 76 76 75
Diabetes 242,464 245,181 247,203 249,440 251,983 254,510 256,298 258,456 260,255
Hypertension 160,843 163,066 164,906 166,733 168,635 170,660 172,304 173,680 175,144
Glomerulonephritis 106,832 107,317 107,882 108,397 108,940 109,570 110,057 110,478 110,794
Cystic kidney 30,326 30,597 30,881 31,127 31,362 31,617 31,815 31,961 32,132
Other urologic 11,111 11,128 11,186 11,205 11,273 11,286 11,357 11,403 11,411
Other cause 56,963 57,412 57,701 58,128 58,383 59,064 59,505 59,763 59,902
Unknown cause 28,387 28,326 28,257 28,299 28,247 28,290 28,251 28,194 28,084
Missing disease 8,202 8,470 8,910 9,232 9,578 9,967 10,387 11,079 12,208
All 645,128 651,497 656,926 662,561 668,401 674,964 679,974 685,014 689,930

^ Data as of June 30, 2015
* Values for cells with 10 or fewer patients are suppressed.
"." Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2013 - 2015Q1
2013 ^ 2014^ 2015^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1
White 19,967 19,022 17,962 18,701 20,014 19,749 18,184 19,180 20,063
Black/African American 8,207 7,761 7,294 7,795 8,322 7,789 7,361 7,592 8,089
Native American/Alaska Native 302 275 252 313 306 275 276 290 293
Asian 1,227 1,141 1,061 1,100 1,266 1,149 1,080 1,156 1,227
Pacific Islander 303 336 318 319 362 326 317 313 338
Other/Unknown * * * * * * * * *
No ME Form 955 886 1,157 1,162 1,193 1,235 1,201 1,454 2,109
Hispanic 4,318 4,058 3,727 4,054 4,397 4,057 3,891 4,120 4,274
Non-Hispanic 25,688 24,477 23,160 24,174 25,874 25,232 23,330 24,413 25,741
Unknown * * * * * * . * *
No ME Form 955 886 1,157 1,162 1,193 1,235 1,201 1,454 2,109
Hemodialysis (%)1 91.6 90.5 89.7 90.0 90.4 89.2 89.9 91.4 90.8
CAPD (%)1 4.2 4.6 5 4.7 4.2 5 4.8 4.4 4.7
CCPD (%)1 4.3 4.9 5.2 5.3 5.4 5.8 5.2 4.2 4.4
Other (%)1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0
Cathether Only (%)2 60.7 59.3 59.3 60.9 61.5 61.4 61.2 61.7 61.8
Catheter w/ maturing AVF (%)2 18.3 18.4 17.8 17.4 17.3 16.9 16.2 17.0 17.2
Catheter w/ maturing AVG (%)2 2.0 2.0 1.9 1.9 1.9 1.8 1.7 1.7 1.7
AVF (%)2 16.3 17.0 17.8 16.7 16.5 16.6 17.5 16.4 16.3
AVG (%)2 2.5 3.0 3.0 2.9 2.6 3.0 3.1 2.9 2.8
Other(%)2 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.2
Unknown(%)2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Pre-ESRD EPO(% Yes)3 15.2 15.5 15.2 14.8 14.3 14.4 14.3 14.0 13.3
Pre-ESRD Nephrology(% Yes)3 69.6 71.4 71.9 71.1 70.6 71.7 72.6 72.2 72.9
Mean Serum Albumin(g/dL)4 3.2 3.2 3.3 3.3 3.2 3.2 3.2 3.2 3.2
Mean Serum Creatinine(mg/dL)4 6.7 6.5 6.6 6.6 6.6 6.6 6.6 6.5 6.6
Mean Hemoglobin(g/dL)4 9.7 9.6 9.7 9.6 9.5 9.5 9.5 9.4 9.4
All 30,963 29,423 28,045 29,394 31,469 30,529 28,422 29,990 32,126
All with ME Form 30,008 28,537 26,888 28,232 30,276 29,294 27,221 28,536 30,017
Dialysis Pts with ME Form 29,388 27,921 26,208 27,556 29,648 28,661 26,577 27,884 29,503
Hemodialysis Pts w/ ME Form 26,908 25,256 23,508 24,809 26,810 25,554 23,902 25,486 26,785

^ Data as of June 30, 2015.
* Values for cells with 10 or fewer patients are suppressed.
"." Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator "Dialysis Patients with ME Form" counts.
2 Vascular access type percentages shown are based on denominator "Hemodialysis Patients with ME Form" counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. "Did patient receive exogenous erythropoetin or equivalent?"
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. "Was patient under care of nephrologist?"
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator "All with ME Form" counts.
4 Mean laboratory test values shown are based on denominator "All with ME Form" counts.